Patents by Inventor Chetan P. Pujara

Chetan P. Pujara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preservative free bimatoprost and timolol solutions
    Patent number: 10058560
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intraocular pressure and treatment of glaucoma.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: August 28, 2018
    Assignee: ALLERGAN, INC.
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • COMPOSITIONS & METHODS FOR LOWERING INTRAOCULAR PRESSURE
    Publication number: 20180228814
    Abstract: Disclosed herein are compositions for lowering intraocular pressure (IOP) of an eye comprising a combination IOP-lowering agents bimatoprost, brimonidine, and timolol. Further disclosed are methods for reducing IOP in the eye of a subject.
    Type: Application
    Filed: September 25, 2017
    Publication date: August 16, 2018
    Inventor: Chetan P. Pujara
  • NON-IRRITATING TESTOSTERONE EMULSIONS
    Publication number: 20180221388
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 9, 2018
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • PRESERVATIVE FREE BIMATOPROST AND TIMOLOL SOLUTIONS
    Publication number: 20180185385
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intraocular pressure and treatment of glaucoma.
    Type: Application
    Filed: August 15, 2017
    Publication date: July 5, 2018
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH
    Publication number: 20180177798
    Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.
    Type: Application
    Filed: August 11, 2017
    Publication date: June 28, 2018
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara
  • Non-irritating testosterone emulsions
    Patent number: 9937188
    Abstract: Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: April 10, 2018
    Assignee: Allergan, Inc.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani, Andrea S. Kim, Mayssa Attar, Ronald Bradford, Rhett M. Schiffman
  • FIXED DOSE COMBINATION OF BRIMONIDINE AND TIMOLOL
    Publication number: 20180078500
    Abstract: Embodiments disclosed herein are directed to fixed compositions comprising brimonidine and timolol for lowering intraocular pressure and treating glaucoma.
    Type: Application
    Filed: March 17, 2016
    Publication date: March 22, 2018
    Inventors: Jim Jiao, Chin-Ming Chang, Anuradha V. Gore, Richard S. Graham, R. Scott Jordan, Sesha Neervannan, Chetan P. Pujara, Jie Shen, Kevin S. Warner
  • Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
    Patent number: 9849140
    Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: December 26, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Kevin S. Warner, Kristin B. Prinn, Chetan P. Pujara, Pramod Sarpotdar, John T. Trogden, Adnan K. Salameh, Guang Wei Lu
  • Compositions and methods for lowering intraocular pressure
    Patent number: 9801891
    Abstract: Disclosed herein are compositions for lowering intraocular pressure (IOP) of an eye comprising a combination IOP-lowering agents bimatoprost, brimonidine, and timolol. Further disclosed are methods for reducing IOP in the eye of a subject.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: October 31, 2017
    Assignee: ALLERGAN, INC.
    Inventor: Chetan P. Pujara
  • Preservative free bimatoprost and timolol solutions
    Patent number: 9763958
    Abstract: The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: September 19, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly, Jie Shen, Marina Bejanian, Rhett Schiffman
  • Compositions and methods for stimulating hair growth
    Patent number: 9763959
    Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: September 19, 2017
    Assignee: ALLERGAN, INC.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara
  • Compositions and methods for stimulating hair growth
    Patent number: 9750750
    Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: September 5, 2017
    Assignee: ALLERGAN, INC.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara
  • TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY
    Publication number: 20170209532
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Application
    Filed: April 10, 2017
    Publication date: July 27, 2017
    Inventors: Anuradha V. Gore, Sai M. Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION
    Publication number: 20170189412
    Abstract: The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.
    Type: Application
    Filed: November 28, 2016
    Publication date: July 6, 2017
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani
  • Two part formulation system for ophthalmic delivery
    Patent number: 9616017
    Abstract: Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: April 11, 2017
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Sai Shankar, Sukhon Likitlersuang, Chetan P. Pujara, Sesha Neervannan
  • COMPOSITIONS & METHODS FOR LOWERING INTRAOCULAR PRESSURE
    Publication number: 20170065610
    Abstract: Disclosed herein are compositions for lowering intraocular pressure (IOP) of an eye comprising a combination IOP-lowering agents bimatoprost, brimonidine, and timolol. Further disclosed are methods for reducing IOP in the eye of a subject.
    Type: Application
    Filed: November 9, 2016
    Publication date: March 9, 2017
    Inventor: Chetan P. Pujara
  • Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers
    Patent number: 9579385
    Abstract: Compositions and methods related to ophthalmic use of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers and therapeutic uses are described herein.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: February 28, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Anuradha V. Gore, Chetan P. Pujara, Richard S. Graham, Melissa Gulmezian, Kristin Prinn, Ramakrishnan Srikumar
  • TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH
    Publication number: 20170035779
    Abstract: Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent the presence or absence of a double bond which can be in the cis or trans configuration and A, B, Z, X, R1 and R2 are as defined in the specification and a penetration enhancer. Such compositions are used in stimulating hair growth of human or non-human animals.
    Type: Application
    Filed: August 19, 2015
    Publication date: February 9, 2017
    Inventors: KEVIN S. WARNER, KRISTIN B. PRINN, CHETAN P. PUJARA, PRAMOD SARPOTDAR, JOHN T. TROGDEN, ADNAN K. SALAMEH, GUANG WEI LU
  • Compositions and methods for lowering intraocular pressure
    Patent number: 9522153
    Abstract: Disclosed herein are compositions for lowering intraocular pressure (IOP) of an eye comprising a combination IOP-lowering agents bimatoprost, brimonidine, and timolol. Further disclosed are methods for reducing IOP in the eye of a subject.
    Type: Grant
    Filed: January 3, 2014
    Date of Patent: December 20, 2016
    Assignee: ALLERGAN, INC.
    Inventor: Chetan P. Pujara
  • Androgen composition for treating an opthalmic condition
    Patent number: 9504646
    Abstract: The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: November 29, 2016
    Assignee: Allergan, Inc.
    Inventors: John T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani